105 Results (Page 1 of 9)
UAE Markets Research Reports
UAE Cardiac Surgery Instruments Market Analysis
The UAE Cardiac Surgery Instruments Market is expected to witness growth from $10 Mn in 2022 to $19 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-2030. The UAE has gained popularity as a destination for medical tourism, especially among patients seeking high-quality treatment at a lower cost. As a result, there is now greater demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include Gulf Scientific Al Mazroui Medical and Chemical Supplies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
UAE Artificial Intelligence (AI) in Healthcare Market Analysis
The UAE Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.04 Bn in 2022 to $0.72 Bn by 2030, registering a CAGR of 46.22% during the forecast period of 2022 - 2030. The market will be driven by government investment in this area and the growing number of private companies working on AI-powered healthcare solutions. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Healthigo & Mubadala Healthcare.
UAE Anti Aging Therapeutics Market Analysis
UAE anti-aging therapeutics market is projected to grow from $3 Mn in 2022 to $11 Mn in 2030 with a CAGR of 17.53% for the year 2022-2030. The market is projected to expand as a result of the growing demand for anti-aging treatments and rising disposable incomes in the UAE. The UAE anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Insilico Medicine, Kuwait Saudi Pharmaceuticals, and Alkahest are the top players in the market.
UAE Healthcare Insurance Market Analysis
The UAE healthcare insurance market is projected to grow from $10.131 Bn in 2022 to $19.6 Bn by 2030, registering a CAGR of 8.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be the increasing population, rising healthcare costs, technological advancements and government support. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include Dubai Islamic Insurance & Reinsurance, MetLife, Abu Dhabi National Insurance, Orient Health, Adamjee, Oman Insurance Company, Ras Al Khaimah National Insurance, Daman, Emirates Insurance and AXA Gulf.
UAE Biomaterials in Healthcare Market Analysis
The UAE Biomaterials in Healthcare Market is expected to witness growth from $781 Mn Bn in 2022 to $2260 Mn in 2030 with a CAGR of 14.20% for the forecasted year 2022-2030. The demand for biomaterials, is rising in UAE as the population increases. As a result, there are now chances for manufacturers of biomaterials to diversify their product lines and grow their market share. The market is segmented by type and by application. Some key players in this market include: Julphar, Mena Medical Supplies, Mena Medical Supplies, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
UAE Healthcare Claims Management Market Analysis
The UAE healthcare claims management market is projected to grow from $133.5 Mn in 2022 to $765.67 Mn by 2030, registering a CAGR of 24.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be mandatory health insurance, emphasis on quality healthcare and technological advancements. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include NAS Neuron Health Services, Nextcare, Aafiya, Optum, GE Healthcare and Cognizant.
UAE ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
UAE's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $148 Mn in 2022 to $284 Mn in 2030 with a CAGR of 8.5% for the year 2022-30. More cases of ADHD being diagnosed in children and UAE and the development of health infrastructure in UAE are the main market drivers. The UAE ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Join Hub Gulf Pharma, Genpharm, and Eli Lilly are some of the key players in the market.
UAE Healthcare Financial Analytics Market Analysis
The UAE Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. UAE’s Healthcare Financial Analytics market will grow as rising healthcare costs, increasing demand for better patient outcomes, and the growing adoption of digital technologies in healthcare. The key market players are Healthbit, Pulsus Healthtech, Fórmula Médica, Kryptus, and others.
UAE Diagnostic Imaging Services Market Analysis
The UAE Diagnostic Imaging Services market size was valued at $2.62 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030 and will reach $4.15 Bn in 2030. The market is segmented by product, application, and end user. The UAE Diagnostic Imaging Services market will grow the prevalence of chronic diseases is rising, demand for minimally invasive operations is rising. The key market players are Emirates Hospitals Group (UAE), Neusoft Medical Systems Middle East FZ LLC (UAE), Emirates Healthcare Group LLC (UAE), NMC Health Plc (UAE), Gulf Imaging and Radiology (UAE), and others.
UAE 3D Printing Medical Devices Market Analysis
The UAE 3D Printing Medical Device Market is expected to witness growth from $15 Mn in 2022 to $53 Mn in 2030 with a CAGR of 17.30% for the forecasted year 2022-2030. Increasing demand for customised medical devices in the United Arab Emirates, technological advancements, rising healthcare spending, and rising awareness of 3D printing technology are some of the major market growth factors for makers in this sector. The market is segmented by product segmented by application, by technology and by end user. Some key players in this market include: Bin Ali Medical Supplies, Immensa Technology Labs, Proto21, GE Healthcare, Stryker and Medtronic.
UAE Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the UAE Liver Disease Therapeutics market will reach a value of $194 Mn from $115 Mn in 2022, growing at a CAGR of 6.7% during 2022-2030. Liver Disease Therapeutics in UAE is dominated by domestic pharmaceutical companies such as Global pharma, Neopharma, and Julphar. The Liver Disease Therapeutics market in UAE is segmented into different types of disease and different therapy types. Some of the significant factors affecting the UAE Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
UAE Home Healthcare Market Analysis
The UAE home healthcare market was valued at $1.83 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.93% from 2022 to 2030 and will reach $3.59 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, many insurances now include home healthcare. The market is segmented by equipment outlook and by services. Some key players in this market are Omega Home Health Care, Ishraq home healthcare, bayti Home Healthcare, Manzil, Mediclinic, NMC Health, and Alleanza.
UAE Oncology Clinical Trials Market Analysis
The UAE oncology clinical trials market is projected to grow from $63.3 Mn in 2022 to $104.7 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the rising rate of cancer in the UAE and investments in developing healthcare infrastructure and research capabilities to support the field. The market is segmented by phase, study design, and indication. Some of the major players include Pfizer Inc, FHoffmann-La Roche Ltd & Julphar
UAE Oral Care Market Analysis
The UAE Oral Care market was valued at $176 Mn in 2022 and is estimated to expand at a CAGR of 7.2% from 2022 to 2030 and will reach $307 Mn in 2030. One of the main reasons propelling the growth of this market is introduction of newer technologies, Technological advancements. The market is segmented by type, drug and distribution channel. Some key players in this market are Dr. Michael's Dental Clinic, Dubai Smile Dental Center, Bin Arab Dental Center, Al Ain Dentistry Perfect, Smile Orthodontic and Cosmetic Dental Center, The dental studio among others.
UAE Multiple Myeloma Therapeutics Market Analysis
The UAE Multiple Myeloma Therapeutics Market was valued at $42 Mn in 2022 and is estimated to expand at a CAGR of 5.5% from 2022 to 2030 and will reach $64 Mn in 2030. One of the main reasons propelling the growth of this Market is Growing demand for innovative therapies, aging population. The Market is segmented by type, drug and distribution channel. Some key players in this Market Julphar, Neopharma, Medpharma, LifePharma, Gulf Pharmaceutical, Pharmax Pharmaceuticals and others.
UAE Diabetes Drugs Market Analysis
The UAE diabetes drugs market size was valued at $308.97 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.1% from 2022 to 2030 and will reach $535 Mn in 2030. The market is segmented by drug type, application, and distribution channel. The UAE diabetes drug market will grow as the UAE government's initiatives to address the diabetes epidemic. The key market players are Neopharma (UAE), Julphar (Gulf Pharmaceutical Industries), Boehringer Ingelheim, and others.
UAE Connected Healthcare Market Analysis
The UAE-connected healthcare market is projected to grow from $331.8 Mn in 2022 to $2608.26 Mn by 2030, registering a CAGR of 29.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be a favourable regulatory environment, strong healthcare infrastructure, government support and growing demand for healthcare services. The market is segmented by type, function and by application. Some of the major players include Healthigo, Etisalat Digital Healthcare, Vezeeta, Cisco Systems, IBM and Philips Healthcare.
UAE Robotic Surgery Services Market Analysis
The UAE Robotic Surgery Service market size was valued at $21 Mn in 2022 and is estimated to expand at a CAGR of 20.3% from 2022-30 and will reach $94 Mn in 2030. The market will grow due to the growing patient population and greater usage of sophisticated automated surgical equipment. The market is segmented by product and service type, application type, and end user. Some of the major players are Dubai Robotics (UAE), Axiom Robotics (UAE), Emaratech (UAE), Next Future Transportation (UAE), Adarma (UAE), and others.
UAE Anemia Drugs Market Analysis
The UAE Anemia drugs market was valued at $80 Mn in 2022 and is estimated to expand at a CAGR of 9.9% from 2022-30 and will reach $170 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Life Pharma, Neo Pharma, New Bridge Pharmaceuticals, Sahara pharmaceutical, GlaxoSmithKline, GlycoMimetics, and Amgen among others.
UAE Neurology Clinical Trials Market Analysis
The UAE Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $43.3 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the modern healthcare infrastructure and a favourable regulatory environment that encourages investment in clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer, and Biogen.
UAE Artificial Intelligence (AI) in Medical Imaging Market Analysis
UAE artificial intelligence (AI) in medical Imaging market size was valued at $8 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.4% from 2022 to 2030 and will reach $90Mn. The market is segmented by AI technology, solution, modality, application, and end User. The UAE is home to some of the world's leading healthcare providers and technology companies. The country has made significant investments in the development of AI technologies, which has led to the availability of advanced AI-based medical imaging solutions. Some of the key players in this market are CureMetrix UAE, HeartVista, Sophia Genetics, AIDoc Medical, Zebra Medical Vision, GE Healthcare, Siemens Healthineers, Philips Healthcare, Fujifilm Medical Systems, Canon Medical Systems, and others.
UAE Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The UAE Primary Hyperoxaluria (PH) Therapeutics market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 5.8% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is government initiatives and an aging population. The market is segmented by diagnostic method, by treatment, and by type. Some key players in this market are Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, OxThera, Qiagen, Sanofi and others.
UAE Alzheimer’s Disease Drugs Market Analysis
UAE Alzheimer’s Disease Drugs market was valued at $77 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.42% from 2022 to 2030 and will reach $158 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Julphar, Lundbeck, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, Roche, Merck & Co., Novartis, Pfizer, and Teva Pharmaceutical among others.
UAE Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the UAE infectious disease therapeutics market will reach a value of $909.4 Mn from $599.35 Mn in 2022, growing at a CAGR of 5.4% during 2022-2030. The Infectious Disease Therapeutics in UAE is dominated by a few domestic pharmaceutical companies such as Medpharma, Julphar and Neopharma. The Infectious Disease Therapeutics market in UAE is segmented into different therapeutic areas and different diseases type. The major factors affecting the UAE infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various the areas of UAE.
UAE Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
The UAE COPD Therapeutics Market was valued at $91 Mn in 2022 and is estimated to expand at a CAGR of 8.1% from 2022 to 2030 and will reach $170 Mn in 2030. One of the main reasons propelling the growth of this market is increase prevalence rate, government initiative. The market is segmented by Drug class and By distribution channel. Some key players in this market are Julphar, Neopharma,b Globalpharma, Medpharma, Pharmaforte, Abbott Laboratories, Almirall, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva Pharmaceuticals and others.